What are the Clinical, Quality-of-Life, and Cost Consequences of 30 Years of Excellent vs. Poor Glycemic Control in Type 1 Diabetes?

The Diabetes Control and Complications Trial (DCCT) demonstrated that intensive therapy for type 1 diabetes delayed the development of microvascular and neuropathic complications compared to conventional therapy. At the end of DCCT, all participants were trained in intensive therapy, care was transferred to community providers, and the difference in HbA1c between treatment groups narrowed and disappeared. Our objective was to describe the outcomes and the quality-of-life and costs associated with those outcomes in participants who maintained excellent vs.

Source: Journal of Diabetes and Its Complications - June 11, 2018 Category: Endocrinology Authors: William H. Herman, Barbara H. Braffett, Shihchen Kuo, Joyce M. Lee, Michael Brandle, Alan M. Jacobson, Lisa A. Prosser, John M. Lachin Source Type: research